Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0002066774-25-000002
Filing Date
2025-05-07
Accepted
2025-05-07 17:36:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5095
  Complete submission text file 0002066774-25-000002.txt   6995
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Subject) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93313 | Film No.: 25923049
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address WILLOW HOUSE, CRICKET SQUARE GRAND CAYMAN Cayman Islands KY1-1107
Business Address WILLOW HOUSE, CRICKET SQUARE GRAND CAYMAN Cayman Islands KY1-1107 64 21 782 797
Sarborg Ltd (Filed by) CIK: 0002066774 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G